| Dr Ryan Michale Balagna, PHD | |
|
363 E 1200 S Ste 201, Orem, UT 84058-6904 | |
| (801) 224-2313 | |
| (801) 224-4475 |
| Full Name | Dr Ryan Michale Balagna |
|---|---|
| Gender | Male |
| Speciality | Clinical Psychologist |
| Experience | 16 Years |
| Location | 363 E 1200 S Ste 201, Orem, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346557428 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC1900X | Psychologist - Counseling | 71334162501 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alliance Behavioral Psychology Llc | 1355436791 | 3 |
News Archive
The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant). This is the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer.
Dr. Fred Gage, a professor in the Salk Institute Laboratory of Genetics and holder of the Vi and John Adler Chair for Research on Age-Related Neurodegenerative Diseases, has been named a 2011 recipient of the prestigious National Institutes of Health (NIH) Director's Transformative Research Projects (T-R01) program.
Today, the U.S. Food and Drug Administration approved Xuriden (uridine triacetate), the first FDA-approved treatment for patients with hereditary orotic aciduria. Hereditary orotic aciduria is a rare metabolic disorder, which has been reported in approximately 20 patients worldwide.
Over the last years, many low and middle-income countries have removed user fees in their health care sector. Researchers from Africa, Asia, Northern America and Europe have studied these policies; their findings are gathered in a supplement of the scientific journal Health Policy & Planning, coordinated by Bruno Meesen from the Antwerp Institute of Tropical medicine.
Glycotope GmbH, a leading glycobiology company, will present recent advances with its GlycoExpress technology of novel human cell lines during the upcoming BIO-Europe in Munich.
› Verified 6 days ago
| Entity Name | Alliance Behavioral Psychology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851583710 PECOS PAC ID: 1355436791 Enrollment ID: O20071001000569 |
News Archive
The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant). This is the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer.
Dr. Fred Gage, a professor in the Salk Institute Laboratory of Genetics and holder of the Vi and John Adler Chair for Research on Age-Related Neurodegenerative Diseases, has been named a 2011 recipient of the prestigious National Institutes of Health (NIH) Director's Transformative Research Projects (T-R01) program.
Today, the U.S. Food and Drug Administration approved Xuriden (uridine triacetate), the first FDA-approved treatment for patients with hereditary orotic aciduria. Hereditary orotic aciduria is a rare metabolic disorder, which has been reported in approximately 20 patients worldwide.
Over the last years, many low and middle-income countries have removed user fees in their health care sector. Researchers from Africa, Asia, Northern America and Europe have studied these policies; their findings are gathered in a supplement of the scientific journal Health Policy & Planning, coordinated by Bruno Meesen from the Antwerp Institute of Tropical medicine.
Glycotope GmbH, a leading glycobiology company, will present recent advances with its GlycoExpress technology of novel human cell lines during the upcoming BIO-Europe in Munich.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ryan Michale Balagna, PHD 363 E 1200 S Ste 201, Orem, UT 84058-6904 Ph: () - | Dr Ryan Michale Balagna, PHD 363 E 1200 S Ste 201, Orem, UT 84058-6904 Ph: (801) 224-2313 |
News Archive
The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant). This is the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer.
Dr. Fred Gage, a professor in the Salk Institute Laboratory of Genetics and holder of the Vi and John Adler Chair for Research on Age-Related Neurodegenerative Diseases, has been named a 2011 recipient of the prestigious National Institutes of Health (NIH) Director's Transformative Research Projects (T-R01) program.
Today, the U.S. Food and Drug Administration approved Xuriden (uridine triacetate), the first FDA-approved treatment for patients with hereditary orotic aciduria. Hereditary orotic aciduria is a rare metabolic disorder, which has been reported in approximately 20 patients worldwide.
Over the last years, many low and middle-income countries have removed user fees in their health care sector. Researchers from Africa, Asia, Northern America and Europe have studied these policies; their findings are gathered in a supplement of the scientific journal Health Policy & Planning, coordinated by Bruno Meesen from the Antwerp Institute of Tropical medicine.
Glycotope GmbH, a leading glycobiology company, will present recent advances with its GlycoExpress technology of novel human cell lines during the upcoming BIO-Europe in Munich.
› Verified 6 days ago
Eric Ghelfi, Psychologist Medicare: Medicare Enrolled Practice Location: 412 W 800 N, Orem, UT 84057 Phone: 801-235-7246 | |
Dr. A Lynn Scoresby, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 703 S State St, Suite #1, Orem, UT 84058 Phone: 801-225-9522 Fax: 801-225-9498 | |
Dr. Bradley Lynn Edgington, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 363 E 1200 S, Suite 201, Orem, UT 84058 Phone: 801-224-2313 Fax: 801-224-4475 | |
Geret Nolan Giles, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 703 S State St, Suite #1, Orem, UT 84058 Phone: 801-225-9522 Fax: 801-225-9498 | |
Heath Dean Granley, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1790 N State Street, Orem, UT 84057 Phone: 801-224-8255 Fax: 801-224-8301 | |
Dr. Melissa Hansen Smith, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1790 N State Street, Center For Change, Orem, UT 84057 Phone: 801-224-8255 Fax: 801-224-8301 | |
Dr. Tyler Adam Money, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1453 N 1200 W, Orem, UT 84057 Phone: 801-734-4945 Fax: 801-734-4946 |